Home › ACADIA Pharmaceuticals Announces Advancement By Allergan Of Novel Glaucoma Compound Into Preclinical Development
 

Keywords :   


ACADIA Pharmaceuticals Announces Advancement By Allergan Of Novel Glaucoma Compound Into Preclinical Development

2013-06-03 11:00:00| drugdiscoveryonline News Articles

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that Allergan, Inc. has advanced an additional product candidate as a potential new treatment for glaucoma

Tags: development compound announces pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »